drugset / Trial / NCT01894308

A Dose Ranging Study to Examine TDS-Testosterone 5%

NCT01894308

RandomizedSingle-groupOpen-labelTreatment

Summary

This study is a continuation of previous studies done in healthy volunteers to prove the efficacy of delivering Testosterone, the male hormone, rapidly across intact skin in s series of doses from low to high in men with low-to-no natural testosterone production to measure their response to the varying doses. The results of this study will inform further studies which will be longer in length, as to the starting doses. The study will be conducted in London, U.K. at the Advanced Therapies Centre, The London Clinic.

Timeline

Start
2026-06
Primary completion
2026-10
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 10 mg Other
Comparator Testosterone Small molecule 30 mg Other
Comparator Testosterone Small molecule 50 mg Other
Comparator Testosterone Small molecule 70 mg Other